Abrupt vessel closure complicating coronary angioplasty: Clinical, angiographic and therapeutic profile  by Lincoff, A.Michael et al.
926
Abrupt Vessel Closure Complicating Coronary Angioplasty :
Clinical, Angiographic and Therapeutic Profile
A. MICHAEL LINCOFF, MD,- JEFFREY J . POPMA, MD, FACC, STEPHEN G . ELLIS, MD, FACC,
JILL A
. HACKER, PAC, ERIC J . TOPOL, MD, FACCt
Ana Arbrx, Michi6'an and Clevefarcd, dill,
To assess the clinical, angiograptie and procedural correlates of
esteems ifler abrupt vessel closure during coronary aegioplasty,
results were analyzed of 109
patients
(8.3%) who had abrupt vessel
clown during 1,319 consecutive coronary augioplasly procedures
perlornrd
between July 1, 1988 and June 30, 1990. These 109
patients had a mean age of 59 ± 11 years; 63% were male, 57% had
had a prior myocardial infarction and 61% had multivessel dhease .
Coronary angioplasty was performed in the settings of acute myo .
carpal infarction 114%) . recent myocardial infarction (36%), uusla-
hle angina (34%) and stable ischenda (29%) .
Abrupt vessel closure occurred at a median of 27 min (range
0 min to 5 days) from the flr ;t balloon inflation . By angiographic
criteria, thrombus or coronary disseclio,l was identified in 20%
and 28% of cases, respectively; both thrombus and dissection
were present in 7 % of closures, and 45% were due to indetermi-
nate mechanisms. Successful reversal of ahenpt vessel closure,
defined as restoration of normal Thrombolysis In Mylaardial
teFarelien (TIM!) grade 3 flaw without resultant Q wave myocar .
dial infarction, emergency bypass surgery or death, was achieved
Abrupt vessel closure complicating coronary angioplasty,
while infrequent, has important clinical consequences . The
National Heart, Lung, and Blood lltstitute (NHLBI)
1985-86 Percutaneous Transluminat Coronary Angioplasty
Registry reported that 20% of all deaths, 40% of myocardial
infarctions and 25% of coronary artery bypass operations
recorded at 1-year follow-up study occurred in the 6
.8% of
patients who had periprocedural coronary occlusion
(1,2) .
Although equipment design and operator experience have
improved steadily since 1977, the proportion of patients
undergoing coronary angioplasty with complex coronary
disease or scale ischemic syndromes has also increased (3) ;
the incidence of abrupt closure has thus remained largely
unchanged (1,4-7)-
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in 47 patients (43%). By hierarchal analysis, the incidence of
death, emergency coronary bypass surgery, Q wave and non-Q
wave rayorardial infarction was 8%, 20%, 9% and IM, reaper.
lively.
Univartate analysis using 23 clinical, morpholog)c and prince .
durat variables demonstrated Ihat successfuloulcame alter abrupt
closure was associated with prolonged balloon infiations (>120 s)
(odds ratio a 6 .87, p < 0,001), unstable angina (adds ratio =
2 .37, p = 0.034) and placement of an intracomnary vent (odds
ratio = 5 .33, p = 0.062)
. By multharlate analysis, independent
correlates of successful outcome were prolonged balloon inflation;
(odds ratio = 5
.11, p = 0.001) and intracaronary stunting (odds
ratio = 4,37, p = 0.049) .
Thus, although prolonged balloon ullatians and latracaranary
stems may improve outcome after abrupt vessel elasnre, the
cumulative risk of morb(di'y a moetalil,, :ao .6,a
significant
sad
mandates Investigation Into improved strategies for its prevention
and treatment .
(J Am Colt Cardlel1992;19 .126-35)
Several novel percutaneous techniques have been devel-
oped that are directed at reversal of abrupt closure or
amelioration of myocardial ischemia caused by vessel occlu-
sion
. Although prior data suggest that standard (8,9), perfu-
sion (10,11) and laser balloon angioplasty
(12), intracoroeary
stenting (13), thrombolylic therapy (14,15). catheterreperfu-
sion (16,17) and intraaortic balloon counterpulsation (l8)
may each be effective in reducing the ischemic consequences
of acute coronary occlusion,
no study has assessed the
ability of these new methods, individually or in combination,
to alter the clinical outcome after abrupt closure . Thus, to
evaluate the efficacy of current strategies for management of
abrupt vessel closure complicating coronary angioplasty, we
retrospectively analyzed our experience over a 2-year period
with 109 consecutive abrupt vessel closures complicating
coronary angioplasty.
Methods
Study patients . From July t, 1988 until June 30, 1990,
1,342 coronary balloon angioplasty procedures were per .
formed at the University of Michigan Medical Center
. In-
formed written consent was obtained for each procedure,
07)5-1o97Nyla5Aa
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and patient confidentiality was maintained during the subse-
qucnt retrospective analysis . Cardiac catheterization or mor-
bidity and mortality records for 23 of these patients were
unavailable for review
. The 1,319 remaining cathetcrization
records were screened for documentation of periprocedural
vessel closure or ischemie complications . Additionally. to
avoid inadvertent exclusion of patients who experienced
in-laboratory abrupt closure without apparent clinical or
hemodynamic sequelae, cineangiograms were also reviewed
for all patients in whom more than three balloon inflations or
balloon inflations lasting >120 s were performed . On the
basis of this initial screening, 302 cineangiograms were
evaluated for angiographic evidence of nhrupt vessel clo-
sure. The 109 patients who met criteria for abrupt closure
form the basis of this study .
Angioplasty procedure. In general, unless such treatment
was contraindicated by a history of allergy or drug intoler-
ance, all patients undergoing coronary angieplasty were
pretreated with aspirin, heparin 410,000-U intravenous bolus
administered 5 to 10 min before angioplasty, with a 5,000-U
bolus repealed hourly throughout the procedure) . nitrates
and calcium channel antagonists . Coronary angioplasty was
performed by methods described in detail elsewhere (19). In
the event of intimal or medial disruption or intracoraaary
thrombus formation at the angioplasty site, final angiography
was performed after an observation period of at least 10 min
while patients remained in the cardiac Catheterizatifin labo-
ratory with the guide wire across the lesion ; in these in-
stances, planned dilation of other target denotes was staged
to a later date and patients were usually treated with a
heparin infusion for 12 to 48 h . Unless anticoaguialion was
clinically indicated because of preprocedural myocardial
infarction or
unstable angina, heparin was discontinued on
completion of uncomplicated angioplasty procedures, and
patients were monitored for at least 18 h in the cardiology
inpatient unit .
Management of abrupt closure
. Although operators fol-
lowed general guidelines based on their interpretation of the
video fluoroscopic images, abrupt closure was managed on
an individual basis without a uniform protocol . After the
angiographic demonstration of abrupt closure, additional
heparin and intracoronary or intravenous nitrates were ad-
ministered. Hemodynuntic instability, defined by a systolic
blood pressure <80 mm Hg unresponsive to crystalloid
infusion, was immediately treated with intravenous met-
araminal, dopamine or intraaonic balloon counterpulsation .
Percutaneous cardiopulmonary bypass was used as adjunc-
tive therapy in the event of cardiovascular collapse . Patients
with persistent hemodynamic compromise despite pharma-
cologic or mechanical support or those with left main
coronary clasnre were usually referred for immediate coro-
nary bypass surgery . Otherwise, coronary dissection was
managed with progressively
longer
balloon inflations until a
satisfactory angiographic result was obtained; the autoper-
fusion catheter was used in patients who were unable to
tolerate prolonged inflations with standard balloons . With a
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significant residual flap. directional coronary atherectomy
was occasionally performed. The Gianturco-Roubin litre-
coronary stent, available at our institution since March 1990,
was implanted in those patients in whom balloon inflations
had failed or were thought likely to fail to reestablish a stable
vess l lumen,
la the absence of contraindications to thrombolytic ther-
apy, tlrunrbat was treated with intracoronary and intrave-
nous administration of urokinase or recombinant tissue-type
plasminogen activator fro-PA), cr both agents ; unless a
substantial intracoronary clot burden was observed, balloon
dilation
was usually performed it thrombolytic treatment
failed so restore adequate vessel patency
. When the morpho-
logic etiology of the closure could not be determined or when
thrombus appeared superimposed on coronary dissection,
repeat balloon dilation, with or without thrombolytic ther-
apy . was generally attempted . Emergency coronary bypass
surgery was usually recommended fur persistent myocardial
ischemia or hemodynamic instability, at which time a "bail-
out" translesienal perfusion catheter or intraaonic balloon
pump was often placed .
Clinical andproceduralvariables. Clinical and procedural
variables were obtained by retrospective review of catheter-
ization laboratory and medical records . Age, gender, prior
myocardial infarction (including the administration (frhrom-
halytic agents within the previous 6 weeks) and previous
angirpiaaty attempts were recorded . Clinical setting was
defined as one or more of the following : acute (w24 h) or
recent (s6 weeks) myocardial inlaection, unstable angina
(nostinfarvtion angina, rest Angina Or crescendo exenienal
angina), or stable ischemia .
Clinical end points included successful reversal of abrupt
closure, procedural succrss (defined as a residual target
stcnosis <50% in diameter), myocardial irq(arcrion, emer-
gency coronary artery bypass Surgery or dealt . Additional
selected definitions were
:
Abrupt vessel closure was considered to be complete
(Thrombolysis In Myocardial Infarction ITIMII [20) grade 0
or I distal flow) or partial (wmseeing stenosis with 11MI
grade 2 distal flow) closure of a previously patent (TIMI
grade 2 or 3) coronary vessel during or after coronary
angioplasty within the period of hospitalization . Abrupt
vessel closure of a previously totally occluded artery was
defined as closure after establishment of TIMI grade 3 flow
doting an initially successful dilation .
Successful reversal of abrnpr vessel closure was defined
by restoration of normal TIMI grade 3 flow beyond the site
of closure without death, need for immediate coronary
artery bypass surgery or development of resultant Q wave
myocardial infarction.
Non-Q wave myocardial infarction
was defined as an
elevation in peak serum creatine kinase (CK) level to >3
times the upper limit of normal with an MB isoenzyme
fraction >3% without the development of pathologic Q
waves or a significant R wave in lead V 1 .
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Angiographic analysts
. Cineangirgrnphic films were re-
viewed by a single experienced angiographer who had no
knowledge of the clinical outcome
. Lesion percent diameter
stenuses were measured by calipers, and the American
College of Cardiology/American Heart Association fACCI
AHA) Task Force stenosis characteristic type (21) as mod-
ified by Ellis et al . (22) and TIME grade coronary flow were
qualitatively graded . On the basis of the angiographic ap-
pearance of the vessel just before and at the time of abrupt
closure, the morphologic cause of closure was defined by
one or more of the following;
Coronary dissection was defined by the presence of a
curvilinear filling defect parallel to the vessel lumen, contrast
medium outside of the vessel lumen persisting after passage
of contrast medium, or a spiral-shaped filling defect partially
or totally obstructing the coronary artery lumen .
Thrombus was defined by the presence of a discrete or
mobile intratuminal filling defect visible at the site of closure .
Indeterminate morphologic cause of closure was present
if the vessel's angiographic appearance was of a radiolucent
or hazy tuminal irregularity or a persistent filling defect that
was neither discrete nor mobile, with delayed amerograde
flow or total coronary occlusion .
Guide catheter closure was present if the site of occlusion
or the proximal e:nent ofdisseclinn was seen to be proximal
,c the target stenosis and adjacent to the lip of the guide
catheter.
Guide wire ale are saws definedby an occlusion at a site of
guide wire manipulation before passage of the angioplasty
cathelerer at a site distal to the balloon near the terminal end
of the guide wire .
When full angiographic views of the closure were not
recorded because of the clinical urgency of the abrupt
closure (six patients) or when cineangiographic films were
not available for review (three patients), morphologic data
were not coded and these portents were excluded from the
analysis of morphologic variables .
Statistical anatvsis . Continuous variables were expressed
as mean values x SD. Differences in dichotomous variables
were compared using the Fisher chi-square significance test
(with the Yates correction when appropriate), and odds
ratios for variables significant to the p < 0.11) level were
calculated . For sequential treatment strategies (inflations of
standard duration, prolonged inflations, intracoronary stenl-
ing and coronary atherectomy), successful outcome was
credited only to the final procedure employed ; intermediate
treatments producing inadequate angiographic results were
coded as failures . Thrombolytic therapy, whose beneficial
eli'ects may he delayed after administration, was considered
to be a concurrent treatment variable when it was used in
combination with other techniques, and was credited with
success or failure according to the final procedural outcome
.
Muitivariate analysis by multiple logistic regression was
performed to identify variables independemly correlated
with outcome, using only these variables significant at the
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Table 1. Baseline Clinical and Angiographic Characteristics of
ACCPAHA = American College of CatdiologyiAmodcan Hess
ASrdrin-
don
: DS =
diameter .)snots; LAD - left antermr descending coronary
artery
: LCx = IcR rircumtcx coronary artery ; all = myocardial infarction :
PICA = coronuy angioplasty; RCA = light coronary artery ; 5V13 =
eaphennns van graft.
p < 0 .10 level in the univariate analysis. Analyses were
performed using SYSTAT (the System for Statistics) .
Results
Patient characteristics and features of abrupt vessel closure
(Tables I and 2)
. During the study period, coronary angio-
plasty was performed in 1,319 patients, of whom 109 (8
.3%)
developed abrupt vessel closure (Table 1) . Notably, >67%
of the 109 patients experienced abrupt vessel closure in the
setting of an unstable coronary syndrome (acute or recent
myocardial infarction or unstable angina) . Nearly 75% of
closures occurred on dilation of lesions with relatively
unfavorable morphology (modified ACCIAHA score B2 or
C)
. Abrupt closure produced complete interruption (TfMI
grade 0 or I flow) of distal coronary perfusion in 83% of
cases, whereas the initial decrease in blood flow was only
partial (T1M1 grade 2) in 17%4-table 2). As assessed by strict
angiographic criteria, thrombus or dissection was identified
as the cause of vessel closure in 20% and 28% of patients,
respectively ; both mechanisms appeared evident in 7% and
the cause of abrupt closure was indeterminate in 45% .
Treatment of abrupt vessel closure. Catheterization labo-
ratory management of abrupt vessel closure is outlined in
109 Patients
Mesa age ! 617 tyri Irargel 59 s 11 (21-iii
Malt Pantries its; 63
Previous VrCA (some site) MI 13
Prior MI
t
:bl 57
Client selling MI
Acme MI 14
Recent 61t ('- ansrabl, angina)
36
Unstable angina 34
Stable ischemia
29
Thrombolytic therapy (56 weeks) inl 18
No . of diseased vessels (stow DSI Inut
1 39
2
36
3 25
vearol dean Imp
LAD 35
LCa 24
RCA 37
svc
4
Modified ACC/AHA lesion score fro)
A B
BI 20
B2
44
C 29
Thranbas before diction !`701 23
Tmal o
c
da,fn e,hln
(%)
20
IACC Vnl
. 19 .N..5
April
1992.92E-35
Table 2 . Clinical and Angiographic Characteristics of Abrupt
Vessel Closure in 309 Talients
Figure I according to angiographic morphology . For the
overall group, repeat balloon dilation was performed in 91 of
the 109 patients, with the size of the ingioplasty balloon
increased by 0 .5 mm in 19 patients. Prolonged inflations
(>120 sl were tarried out m73 patients, over half of whom
had undergone preceding unsuccessful inflations of shorter
duration ; the Stack autoperfusian balloon catheter was re-
quired in 7 patients, Available for clinical use during the last
3 months of the study period, the Gianturco-Roubin intr,-
coronary stem was used in 9 of the 22 closures occurring
during that time . Directional atherectomy was performed in
an additional 2 patients. Thrombolytic agents were adminis-
tered to 43 patients after acute coronary occlusion (rt-PA in
7, urkirase in 29, both rt-PA and urokinase in 7)
. 8146 of
whom also underwent repeat balloon inflations . Doses
ranged from 0 .5 to 3 million U of urokinase and 20 to 100 U
of in-PA
. A total of 17 patients were referred for coronary
artery bypass surgery after unsuccessful attempts at resolu-
tion of closure in the catheterization laboratory .
Of the 54 patients with closure of indeterminate morpho-
logic cause, 28 underwent mechanical attempts to reestab-
lish vessel patency (balloon inflations, stenting or directional
atherectomy), 4 received thrombolytic agents only and 19
were treated with combined therapy . In contrast, throm-
bolytie agents were used significantly less frequently in the
patients with coronary dissection (only 6 of 35, 3 of whom
had angiogrnpltieally visible thrombus associated with the
dissected lesion). Two thirds of patients in the dissection
group
were treated with a combination of standard or
prolonged balloon inflations ; intructuranary shearing or
athmecti my was used in three patients and one patient,
respectively
. Intracoronary thrombus leading to abrupt ves-
sel closure was treated with thromholytic therapy in 70% of
cases, although the majority of patierts with this morpho-
logic cause of closure also underwent repeat balloon dila-
LINl :OFF FT AL..
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Lions . The intracoronary stem was used in two of these
patients, neither of whom had been treated with thromboly-
515 .
Z
IIn unly II patients was no at tempt made Ira perform oith,or
repeat dilation or thromholysis . Of these 11 patients, 8
underwent immediate bypass surgery with left main coro-
y artery closure (n = 2). shock (n = 3) or failure to pass
guide wire (n = 31: an additional 3 patients were treated
medically for closure of the infarct-related vessel during
rescue angiuplasty for acre myocardial infarction .
Hemoderutnk insmbitity occurred in 34 patients (31%)
with abrupt vessel closure
; instability was successfully re-
versed in 22 . An intraaertic balloon pump was placed in 17
patients
: in I I patients with hemodynamic compromise, in 5
as a bridge to coronary bypass surgery and in I elderly
patient treated medically for refractory closure . Percutane-
ous cardiopulmonary bypass was instituted in four patients
with hctudynamic collapse, three of whom had remained in
unstable condition despite intraaurtic balloon countcrpulsa-
tlon. Hemodynamic stability was restored in three of four
patients, although only two survived to hospital discharge .
Clinical outcome of abrupt stool closure (FIg
. 2). Abrupt
vessel closure was successfully reversed in 47 (4316) of 1119
patients, and procedural success, defined by dilation to
<59 residual stenosis,
was accomplished in 42 patients
(381
/Q_ Of the 47 patients in whom reversal of abrupt closure
was considered successful . postprecedural CK determina-
tions were obtained in 32 )68%) ; excluding the 6 patients in
whom angioplasty was performed in the selling of acute
myocardial infarction, 0 patients had elevated (>3 limes
upper limit of normal) peak CK keels of 1,135
;
560 1Ulliter, Thus, among "snecessfuny - ' managed patients
with abrupt vessel closure whose CK values were measured,
the incidence of resultant non -Q wave myocardial infarction
was approximately 30% .
Ofihe 62 patients with an
unsuccessful
oatcome, 9died (3
after coronary bypass surgery, 5 of refractory cardiogenic
shock in the catheterization laboratory and t with multiple
complications including cerebrovascular
hemorrhage 13
days after abrupt vessel closure and intracc renary stenting)
•
Notably, three affirms patients with abrupt closure involving
the left main coronary artery (during angioplasty of the left
anterior descending or circumflex artery) died . Successful
coronary bypass surgery was performed in 22 patients, in
whom postprocedurat CK determinations and electrocardio-
grams (ECC s) were not routinely obtained . Of the remaining
31 palicnts with unsuccessful treatment of abrupt vessel
closure, 10 had a Q wave myocardial infarction (peak CK
2,148 ± 1,530 Whiter), 4 developed a non-Q wave myocar-
dial infarction (peak CK 662 = 193lUJliter), 8 had undergone
rescue angioplasty for ongoing acute myocardial infarction
(development of Q waves or CK elevation could not be
ascribed to the abrupt closure) and 9 had
uo clinical se-
quelae, even though TLMI grade 3 floweould not be restored
across the site of closure
. Two patients (t .0%) in whom
abrupt closure was initially reversed in the catheterizatioil
Complete closure IX1 E3
Partial Closure (%)
17
Median time of basal (-gel
from Ist bettor inlatian)
Location at closure i 19)
Calhelerieatianlaboratory
Pcstpracedpre bay area
Inparinetunll
Mechanism of" .." t9c 1
Guide catheter
27 min 10 min to! day,)
10
Guide wire al tarsi lesion
8
Guide wire distal to target lesion 1
Balloon catheter
Morphologic cause
of closure Iwi
Thrombus
sl
20
Dissection
Thrombus + disscclion 7
lndelermlnme 45
Hemonynwnic instabllicy ICI
72
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laboratory subsequently (at 2 .5 and 46 h, respectively)
developed reclosure that was unsuccessfully managed ; no
patient with late reclosure had a successful outcome,
The cmnrdative risk of morbidity and mortality (death,
emergency coronary bypass surgery, Q wave or non-Q wave
myocardial infarction) for the entire group of 109 patients
with abrupt vessel closure was 40%
. This value most likely
underestimates the morbidity of closure, because it does not
include the 14
patients who developed ECG Q waves or CK
elevation in the setting of rescue angioplasty for acute
myocardial infarction.
Correlates of successful reversal of abrupt vessel closure .
Table 3 summarizes rates of successful resolution of abrupt
closure with different treatment modalities for each of the
three angiographic rorphologic causes of closure . Throm-
bolytie therapy w
sue essful in every case in which it
was used alone . and concomitant administration of throm-
bolytic agents at any dose employed did not improve the
likelihood of success with other management techniques .
Figure 1. Diagram illustrating the management at ataupt vessel
closure in 109 patients. Patients are grouped according to the
angiographic morphologic cause of closure as indeterminate (n = 54,
including the 6 patients with inadequate visualization of closure and
the 3 whose cincangographic films were unavailable) . dissection
(n = 35, including the 7 patients with mi ked dissection and thrombus
morphology) and thrombus (n = 20)
. Ather = coronary atherec-
tomy; CABG = coronary artery bypass graft surgery ; F = failed
resolution of closure ; Long = repeat balloon inflations of duration
?120 s : LvRc = tntmvenous OF
inlracoronary administration of
ombinant tissue-type plasminogen activator, urokinese, or both
agents ; Rx = treatment: S = successful resolulion
of closure; Std =
repeat balloon inflations of duration <120 s .
Tutel =109,
7
t+ s-t
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Notably . thrombolytie therapy appeared to
be equally inef-
fective for treating intracoronary thrombus, dissection and
closure of indeterminate morphology
. Similarly, balloon
inflations of standard duration (<120 s) were rarely sufficient
to restore an adequate angiographic appearance . Irrespec-
tive of the morphologic causes of closure, however, pro-
longed balloon inflation resulted in successful resolution of
closure in nearly 50%n of patients in whom it was performed
.
An intracoronary stenL, used in nine patients over a 3-month
period, produced an excellent angiographic result in every
ease . although one patient subsequently died of multiple
complications and another had a Q wave myocardial infarc-
tion during the 3-h elapsed lime between big out-of-
laboratory vessel closure and its treatment
. Both patients
undergoing directional atherectomy had successful resolu-
tion of vessel closure .
Clinical, angiographic and procedural correlates
of suc-
cessfnt ontcome after abrupt vessel tdosare are listed
in
TtSle 4 . By univariate analysis, prolonged balloon inflations
(p < 0 .001) . unstable angina (p = 0.034) and intracaronary ,
stealing (p = 0 .062) were associated with a successful
outcome to a significance level of p < 0 .10, whereas stable
ischemia (p = 0,04), guide wire-induced closure (p = 0.061),
and closure during angioplasty of the left anterior descending
coronary artery (p = 0.075) were associated with unsuccess-
ful outcome
. Notably, closure morphology (thrombus or
dissection) had no demonstrable correlation with the likeli-
hood of successful outcome or with the effectiveness of the
various treatment strategies . With use of multivariate anal-
ysis, two factors were found to be independent correlates of
successful resolution o`,iosur-: prolonged balloon inflations
JACC Vol. 19. No . 5
April 1992:926-3!
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Figure 2. Chart illustrating final hierarchic (death, emergency cor-
onary bypass surgery, Q wave myocardial infarction . non-Q wave
myocardial infarction) outcome for all 109 patients after abrupt
vessel closure, The shaded pie slices represent unsuccessful outcome
among 57`% of patients ; the white slices successful resolution in 43
of patients . MI = myocardial infarcrion : ongoing MI = Lsstiems
undergoing rescue angioplasty for acute myocardial infarction, in
whom development ofQ waves or seturn creatine kill elevations
could not be attributed to abrupt closure ; other ahbrevianons as in
Figure 1 .
(odds ratio = 5 .11, p = O
.W1' and intracoronary scenting
(odds ratio = 4
.3'5, p = 0.049) .
Discussion
In the current series, abrupt vessel closure complicated
109 (8.3%) of 1319 angieplasty procedures performed over
the 2-year period from July 1988 through June 1990 . Despite
the availability
of a wide array of adjunctive treatment
methods and support devices, successful resolution of
abrupt vessel closure was accomplished with percutaneous
techniques in only 43% of patients
. Abrupt closure carried a
substantial risk of morbidity and mortality ; by hierarchal
analysis, 8% of patients died, 20% required emergency
bypass surgery and at least 9% and 11%. respectively, had a
Q wave or non-Q wave myocardial infarction. Moreover,
even among "successfully" managed patients, a non-Q
wave myocardial infarction occurred in approximattily 2 .
Table 3. Rates of Successful Resolution of Abrupt Closure With Different Treatment Modalities in 109 Patients
Rx = treatment
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Multivariate analysis demonstrated that prolonged balloon
infations and intracoronary scenting were independently
correlated with successful outcome .
Incidence and clinical consequences of abrupt vessel clo-
sure
. Depending on the definition used, the reported inci-
dence of abrupt vessel closure after coronary angioplasty
has been variable (Table 5). Although the 8 .3% incidence
rate of abrupt closure in the present series is higher than may
be expected from prior work . psevkms studies have often
cxcluded patients with incomplete reduction in coronary
perfusion (6,23), angioplasty for acute myocardial infarction
(4 .24), in-laboratory closure (25.26) or closure preceding
successful angioplasty (6.23). The reported incidence of
abrupt closure in this study, therefore, may more accurately
reflect the expected frequency of abrupt closure in a more
heletageneo us group of patients undergoing coronary angic-
plasty.
In the present series, nearly 9n% of vessel closures
occurred while the patient was in the eatheterization labora-
tory or adjacent holding area Although this frequency of
in-laboratory closures may be slightly higherthan the 71% to
8'Dq incidence rate reported by other groups (2 _3,24), the
rigorous criteria fur review of eiueangiegrams in this study
may have detected more patients with transient in-
laboratory closure than were detected in prior analyses .
Similar to earlier reports 42,23) . abrupt vessel closure was
successfully reversed in nearly 50% of patients . Although
the mortality rate of 8-3% in the current series is higher than
the 2% to 6% mortality rates previously reported 12 .4,23,24),
high risk subgroups such as patients with acute myocardial
Infarction were included in the present analysis . The 20%
incidence ram of emergency bypass surgery and 20% inci-
dence rare of periprocedural myocardial infarction in this
series compares favorably with rates in prior studies .
Predictive factors of abrupt closure . Several clinical and
angiographie features have been associated with a height-
ened risk of procedural complications during coronary an-
gioplasty. These clinical correlates include unstable angina
(27), diabetes mellitus (22), inadequate antiplattlet therapy
(28),
female gender (4) and extreme age (29).
Two Large
series (4.221 have also demonstrated that angiographic fac-
Indrlermirerr Gsseclion T7nombus
Treatmael a
suss
Rates
n
Success
pale n
Success
Rate
Overall
Success Rate
TNamhalytic agent only 4
all, I
05"1 I nIr'. 2%
Other Its with lhmrnbolytic agents 19 387E 5
40% 12 5011 23%
Otter Ra wirtatar Ihmmbolytic agents
29 4654 24 39% 3 67% 445E
Inaarions of slandaid duratbn 30 111 17
6%
10 10% 511,
Pralceredinthlbru
37 54k
22 4111 14
43, 40%
Intneosnrrsy stem 4 75% 3 100% 2
54% 79%
Directional alhernctany I IM59 1 100%
1rev
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Table 4, Clinical and Procedural Coerelotes of Successful Reversal of Abrupt Vessel Closure
tort such as lesion length, stenosis bend aragulation >45°,
excessive proximal vessel torluusity, inoraluminal thrombus,
other stenoses in the same vessel, multivessel disease and
the modified ACCIAHA Task Force lesion score are associ-
ated with increased risk for major
complications . Although
these and other correlates of procedural cdmpficntions may
serve to stratify groups of patients according to anticipated
risk, they generally have a low positive and negative predic-
tive value (30) ; closure thus remains largely unforeseeable .
Further, high risk characteristics are encountered commonly
in clinical practice and may not be avoidable in those
patients for whom angioplasty remains the preferred option
for revascularication
.
Profile of viol closure. Strict criteria were applied to the
angiographic identification of the probable cause of closure
in the present series . Nearly 45% of morphologic causes of
closure were indeterminate, many of which probably repre-
sented thrombus superimposed on a coronary dissection.
Coronary artery vasospasm, with acute reduction of lumen
diameter by up to 30%, has been shown (31) to occur
routinely after balloon angioplasty and may be an important
initiating event in the development of abrupt vessel closure .
The lack of demonstrable angiographic improvement with
CI - confidenee interval : LAO = lee anterior daooaedina coronary a nary ; LCx - La circumflex coronary
artery ; MI = myocardial infarctnn ; RCA = right coronary artery .
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intracoronary or intravenous nitrates among patients in the
current series, however, indicates that vasospasm was likely
nor the predominant mechanism of closure, a finding consis-
tent with those or the NHLEI Percutaneous Transluminal
Coronary Angioplasty Registry (3) . Somewhat surprisingly,
the angiographic morphologic causes of closure did not
influence the likelihood of resolution or the suitability of
mechanical versus pharmacologic management strategies in
this analysis. This finding may reflect the difficulty in differ-
collating between thrombus and dissection by nnglographic
appearance alone . Newer imaging modalities such as intra-
coronary ultrasound or aogioscopy
may
offer greater utility
in defining the mechanism of abrupt closure, with possible
improved correlation between the morphologic causes of
closure and outcome of various therapies .
Hemodynamic fnsiabilily accompanied 313E of vessel
closures in this series, although this complication was not a
significant predictor of adverse outcome and was success-
fully reversed in >110% of cases. This favorable result may
be related to the prompt availability of various methods of
pharmacologic and hemodynamic support, the latter includ .
ing the autoperfusion ha" (Stack) and 'bailout" cathe-
n
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Table 5 . Reported Incidence of Abrupt Closure Compticaline
Coronary Angioplasty
No, or
	
Incidmre of
swdyIrer.t
panem, AnmplClosure
NHLH1 121 1 .801
6 172)
wary (4) 4.772 4 .472
Boss Israel (23) 1 .151 4.79
ROKardam(24)
1423 7.3%
Current
:c299 1 .319 5372
tern, the inlraaortic balloon pump and emergency percula-
nevus cardiopulmonary bypass.
Unsuccessful resolution ofabrupt closure was associated
by univariate analysis with Angioplasty of the left anterior
descending coronary artery . Although the reason for this
association has not been defined, it is nicely related to the
substantial area of myocardium at risk for infarction during
closure of this artery ; death doe to abrupt closure was more
frequent in patients with closure after left anterior descend-
ing artery angioplasty (death occurred in 16% and 4% of
patients with left anterior descending and other vessel clo-
sures, respectively, p = 0 .084) .
Treatmed of closure
. This study extends previous anal-
yses by focusing on the efficacy of current calhaerization
laboratory strategies in reversing established abrupt vessel
closure . With multivariate regression analysis, two proce-
dural variables were associated with a four- to five-fold
improvement in the likelihood of successful reversal of
abrupt closure: prolonged (>120 s) balloon inflations and
inlracoroutary steeling . Previous studies have suggested that
prolonged balloon inflation may improve the immediate
result after coronary angioplasty (32) and help reverse failed
angioplasty (10) . This effect may be due to improved remod-
eling of atherosclerotic obstruction or "Locking up" of a
coronary dissection flap. The association between prolonged
inflations and favorable outcome in the present series may.
to
an extent, reflect the adverse prognosis for patients in
whom therapeutic options were limited by inability to re-
cross the zone of occlusion . Nevertheless, prolongation of
balloon inflation to >120 s had a salutary effect on the
reversal of abrupt
closure,
whereas such benefit was not
evident in patients treated only with inflations of standard
duration. Symptomatic and hemodynamic tolerance of
long
balloon inflations may have reflected less underlying com-
promise following coronary occlusion and biased toward a
favorable outcome independently of the effect of prolonged
inflation as such ; the retrospective nature of this study did
not permit evatualion of this possibility-
The Cfeetareo-Rorebin intracoronary srenr (33
), a lad-
loon-expandable flexible stainless steel coil currently order
investigation for the treatment of abrupt vessel closure, is
designed to compress obstructive dissection flaps against the
vessel wall and optimize blood flow across the lesion. These
scents have been placed for actual or threatened acute
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closure in 42 patients in one series (34). During the current
study . 9 of 22 cases of abrupt closure occurring during the
period wherein wears were available were managed with
stent placement, with successful resolution in 7 patients
(78%). Notably, the two patients with an adverse clinical
outcome had a successful angiographic result. Although the
sample size was small, the sabsl tial beneficialelfeet otthis
technique in the management of abrupt vessel closure war-
rants validation in larger groups of patients .
Other cenrerr have reported enliiar improvements in
outcome whit new modalities for irearmenr of abrupt Flo-
sure. 1 :3ser balloon angioplasty was used in 85 patients ilh
severe dissection or abrupt vessel closure in a recent series
(351, with an 85% rate of prevention of emergency hypau
surgery . Directional coronary atherectomy was used for
rescue in 30 patients with failed coronary Angioplasty, with
an overall success rate of 87%a (36). In our study, atherec-
tamy was used in only two patients with abrupt closure, both
of
whom had a successful outcome .
Despite the relatively large number of patients in this
series receiving thrombulytie therapy for abrupt vessel coo-
slue (43 patients), no beneficial trend was observed at any
dose used, irrespective of th° angiographie morphologic
cause of closure . This finding is supported by those of
related studies, in which prophylactic administration of
inlracoronary urokinase during coronary angioplasty (14)
and treatment of abrupt vessel closure with streptokinase
(24) did nut reduce the incidence of major complications . 1n
view of the associated bleeding risk, particularly if emer-
gency bypass surgery is required, it may be worthwhile to
consider possible alternatives before thrombolyRC agents are
administered for abrupt closure
.
Limitmiam. The current study has several important
limitations. First,
although the present analysis provides
nearly complete in-hospital follow-up for "hard" clinicallend
points such as death, emergency bypass surgery and angio-
graphic restoration of patency, complete ECU, enzymatic
and hemodynamic data were not available far all patients .
Notably, because of the limited specificity and sensitivity of
new ECG Q waves or elevations in serum CK MB in the
postoperative setting (37k an ECG and CK deterndnatioos
were not routinely obtained in patients aftereormtary bypass
surgery. Moreover, CK levels were not measured in 32% of
patients with successful resolution of abrupt vessel closure-
Because such patients tended to be those in whom closure
responded promptly to trident (and therefore had a rela-
lively
low likelihood of sustaiaing substantial myocardial
necrosis), it is possible that our data
overestimate the
frequency of non.Q wave infarction after successful therapy .
Nevertheless, the failure to obtain postprocedural CK deter-
minalions in all patients experieneirg in-laboratory vessel
closure during the study period corntiluted suboptimal clin-
ical practice, and current laboratory protocols require CK
measurements in patients after even transient coronary
vessel closure.
Second, the treatment strategiesforabrupt vessel closure
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were not controlled and randomized in the present retro-
spective study, and with small numbers of palicnts in certain
treatment subgroups, the true effect of these strategics may
be difficult to assess . Nevertheless, this analysis provides a
review of these management techniques when applied in a
generally accepted manner based on the angiographic ap-
pearance of the vessel at the time of closure . Third. fol-
low-up data after the hospitalization period were not ob-
tained in our series, and issues of long-term outcome such as
rcstenosis and late coronary bypass surgery after abrupt
vessel
closure could not be addressed . However, other
recent studies of abrupt vessel closure have addressed this
issue (2,24,38). The NHLBI Registry (2) documented excess
rates of death and bypass surgery in patients with abrupt
closure after' angioplasly, and the incidence of rcstenosis
after successful treatment of abrupt closure was 57% in a
recent series from Emory University (38) .
Conclusions. Abrupt vessel closure complicating coro-
nary angioplasty remains an ominous event
. with a high
cumulative risk of morbidity or mortality. Short-term out-
come may be improved by the performance of prolonged
angioplasty balloon inflations after vessel closure . with an
added benefit derived from intracoronary stenting in selected
cases. No other treatment
strategy studied, including throm-
bolytie therapy, was associated with improvement in final
result . Although this study is subject to the limitations
inherent in a retrospective analysis, these data serve to
provide a current framework for management of abrupt
vessel closure and underscore the need for new strategies
for
its prevention and treatment .
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